Ischemic preconditioning decreases postischemic myocardial tumor necrosis factor-α production: Potential ultimate effector mechanism of preconditioning

Circulation

Volumn 98, Issue 19 SUPPL., 1998, Pages

  Meldrum, Daniel R ^a,b   Dinarello, Charles A ^a   Shames, Brian D ^a   Cleveland Jr , Joseph C ^a   Cain, Brian S ^a   Banerjee, Anirban ^a   Meng, Xianzhong ^a   Harken, Alden H ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Cardiopulmonary bypass; Cardiovascular diseases; Immunology; Ischemia; Reperfusion

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASE; CONDITIONING; CONTROLLED STUDY; EFFECTOR CELL; GRAFT REJECTION; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0345516048     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Meldrum DR. Tumor necrosis factor in the heart. Am J Physiol. 1998; 274:R577-R595. Review.
2. Oral H, Dorn GW, Mann DL. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-α in the adult mammalian cardiac myocyte. J Biol Chem. 1997;272:4836-4842.
3. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian cardiac myocyte. J Clin Invest. 1993;92: 2303-2312.
4. Gurevitch J, Frolkis I, Yuhas Y, Lifschitz-Mercer B, Berger E, Paz Y, Matsa M, Kramer A, Mohr R. Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion. J Am Coll Cardiol. 1997;30:1554-1561.